"2019 is the year when the training wheels come off and the world gets to see what CRISPR can really do for the world in the most positive sense," says Fyodor Urnov, a gene-editing scientist at the Altius Institute for Biomedical Sciences in Seattle and the University of California, Berkeley. Here are highlights of the year ahead in CRISPR research, and answers to common questions about the technology.
The Livio AI, as the new device is called, uses tiny sensors plus, as its name suggests, artificial intelligence to selectively filter noise and focus on specific sound sources—for instance, the person across the table in a busy restaurant—while also tracking various health metrics, including steps walked, stairs climbed, and cognitive activity, such as how much the wearer is talking and engaging with other humans.
Cardiologists and cardiac surgeons at PMCC are the first to use true holographic imaging in real time during a medical procedure. The technology was produced in Israel and brought to Canada to be used at Toronto's UHN. "This unique and unprecedented event represents a breakthrough in our ability to see inside the heart without making an incision, and will allow our physicians to treat heart disease with exceptional confidence and accuracy," said Medical Director of the PMCC, Dr. Barry Rubin.
The Starkey Livio AI is the first hearing aid to introduce multiple sensors. These sensors mean that the hearing aid can track your daily activity such as how many steps you take, along with other features like fall detection and social engagement.
On the 20th March 2019 Starkey launched the Livio AI hearing aid. This was the biggest event of the year because it is the first hearable hearing aid. What I mean by this, is that the Starkey Livio AI is the first hearing aid to introduce multiple sensors. These sensors mean that the hearing aid can track your daily activity such as how many steps you take, along with other features like fall detection and social engagement. [See related Video]
Professor Mashudu Tshifularo and his team at the University of Pretoria performed the world’s first middle-ear surgery using 3D technology! They effectively replaced the hammer, anvil, stirrup and the ossicles that make up the middle ear. The surgery, which can be performed on everyone including newborns, has benefitted two patients already. The 3D-printing technology is used to print these bones, and is also used in surgery to reconstruct the ossicles.
Diagnosing an illness requires taking in a lot of information and connecting the dots. Artificial intelligence may be well-suited to such a task and in recent tests one system could diagnose children’s illnesses better than some doctors.
A $1.5 million federal grant will be used in coming months to determine how photobiomodulation (PBM) therapy can be used to heal - and help prevent - mucositis in a safer, more effective way. Researchers at Roswell Park and the University at Buffalo make up one of five teams that hope to gain approval of the treatment for use across the United States this year.
If you bled when you brushed your teeth this morning, you might want to get that seen to. We may finally have found the long-elusive cause of Alzheimer’s disease: Porphyromonas gingivalis, the key bacteria in chronic gum disease. That’s bad, as gum disease affects around a third of all people. But the good news is that a drug that blocks the main toxins of P. gingivalis is entering major clinical trials this year, and research published today shows it might stop and even reverse Alzheimer’s.
As public health officials tackle opioid addiction and overdoses, another class of prescription drugs has been contributing to a growing number of deaths across the United States. Benzodiazepines, such as Valium and Xanax, are commonly prescribed for anxiety and insomnia.